...
首页> 外文期刊>BMC Complementary and Alternative Medicine >Biochemical characterization and 1 H NMR based metabolomics revealed Melicope lunu-ankenda leaf extract a potent anti-diabetic agent in rats
【24h】

Biochemical characterization and 1 H NMR based metabolomics revealed Melicope lunu-ankenda leaf extract a potent anti-diabetic agent in rats

机译:生化特征和基于1 H NMR的代谢组学揭示了Melicope lunu-ankenda叶提取物在大鼠中是一种有效的抗糖尿病药

获取原文
           

摘要

Background Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by continuous hyperglycemia associated with insulin resistance and /or reduced insulin secretion. There is an emerging trend regarding the use of medicinal plants for the treatment of diabetes mellitus. Melicope lunu-ankenda (ML) is one of the Melicope species belonging to the family Rutaceae. In traditional medicines, its leaves and flowers are known to exhibit prodigious health benefits. The present study aimed at investigating anti-diabetic effect of Melicope lunu-ankenda (ML) leaves extract. Methods In this study, anti-diabetic effect of ML extract is investigated in vivo to evaluate the biochemical changes, potential serum biomarkers and alterations in metabolic pathways pertaining to the treatment of HFD/STZ induced diabetic rats with ML extract using 1H NMR based metabolomics approach. Type 2 diabetic rats were treated with different doses (200 and 400?mg/kg BW) of Melicope lunu-ankenda leaf extract for 8?weeks, and serum samples were examined for clinical biochemistry. The metabolomics study of serum was also carried out using 1H NMR spectroscopy in combination with multivariate data analysis to explore differentiating serum metabolites and altered metabolic pathways. Results The ML leaf extract (400?mg/kg BW) treatment significantly increased insulin level and insulin sensitivity of obese diabetic rats, with concomitant decrease in glucose level and insulin resistance. Significant reduction in total triglyceride, cholesterol and low density lipoprotein was also observed after treatment. Interestingly, there was a significant increase in high density lipoprotein of the treated rats. A decrease in renal injury markers and activities of liver enzymes was also observed. Moreover, metabolomics studies clearly demonstrated that, ML extract significantly ameliorated the disturbance in glucose metabolism, tricarboxylic acid cycle, lipid metabolism, and amino acid metabolism. Conclusion ML leaf extract exhibits potent antidiabetic properties, hence could be a useful and affordable alternative option for the management of T2DM.
机译:背景技术2型糖尿病(T2DM)是一种代谢紊乱,其特征是与胰岛素抵抗和/或胰岛素分泌减少相关的持续性高血糖症。关于使用药用植物治疗糖尿病的趋势正在出现。 Melicope lunu-ankenda(ML)是属于芸香科的Melicope物种之一。在传统药物中,已知其叶子和花朵具有极大的健康益处。本研究旨在调查Melicope lunu-ankenda(ML)叶提取物的抗糖尿病作用。方法在本研究中,对ML提取物的抗糖尿病作用进行了体内研究,以评估使用ML提取物使用 1 <来治疗HFD / STZ诱导的糖尿病大鼠的生化变化,潜在的血清生物标志物和代谢途径的改变。基于H NMR的代谢组学方法。用不同剂量(分别为200和400?mg / kg BW)的Melicope lunu-ankenda叶提取物处理2型糖尿病大鼠8周,并检查血清样品的临床生物化学。还使用 1 1H NMR光谱结合多变量数据分析对血清进行了代谢组学研究,以探索区分血清代谢物和改变代谢途径的方法。结果ML叶提取物(400?mg / kg BW)处理可显着增加肥胖糖尿病大鼠的胰岛素水平和胰岛素敏感性,同时降低葡萄糖水平和胰岛素抵抗。治疗后还观察到总甘油三酯,胆固醇和低密度脂蛋白的显着减少。有趣的是,治疗大鼠的高密度脂蛋白显着增加。还观察到肾损伤标志物和肝酶活性的降低。此外,代谢组学研究清楚地表明,ML提取物显着改善了葡萄糖代谢,三羧酸循环,脂质代谢和氨基酸代谢的紊乱。结论ML叶提取物具有有效的抗糖尿病特性,因此可能是治疗T2DM的有用且负担得起的替代选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号